| Primary information |
|---|
| CancerPPD ID | 4597 |
| PMID | 21403917 |
| YEAR | 2011 |
| SEQUENCE | RGGRLCYCRRRFCVCVGR |
| LENGTH | 18 |
| NAME | Protegrin 1 |
| C-ter Modification | Amidation |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | L |
| Non-Natural | None |
| NATURE | Antimicrobial |
| ACTIVITY | IC50 =30-40 µg/ml |
| SOURCE | alpha helical peptide without cysteines |
| Cancer Type | Lymphoma Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Blood |
| CELL LINE | U-942 |
| TEST TIME | Not Available |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | CCSEEEEEETTEEEEEEC |
| SMILES | [NH3][C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)C(C)C)CSSC1)C(C)C)CSSC2)Cc1ccccc1)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc1ccc(cc1)O)CC(C)C)CCCNC(=[NH2])N)CCCNC(=[NH2])N |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|